 develop iddm kidney diabet sibl goal studi patient insulin-depend diabet iddm kidney sibl possibl solut occurr man islet cell autoantibodi ica part screen program first-degre rel iddm year kidney hla-ident sibl long-stand iddm oral intraven glucos toler test gradual loss insulin secret glucos intoler patient iddm yr nephrectomi presenc ica absolut contraind kidney donor nonetheless ica test individu risk subsequ iddm posit